Michael T. Dellinger

3.2k total citations
54 papers, 2.4k citations indexed

About

Michael T. Dellinger is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Michael T. Dellinger has authored 54 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 26 papers in Oncology and 13 papers in Surgery. Recurrent topics in Michael T. Dellinger's work include Lymphatic System and Diseases (25 papers), Vascular Malformations and Hemangiomas (11 papers) and Angiogenesis and VEGF in Cancer (7 papers). Michael T. Dellinger is often cited by papers focused on Lymphatic System and Diseases (25 papers), Vascular Malformations and Hemangiomas (11 papers) and Angiogenesis and VEGF in Cancer (7 papers). Michael T. Dellinger collaborates with scholars based in United States, France and Italy. Michael T. Dellinger's co-authors include Rolf A. Brekken, Marlys H. Witte, Bjørn R. Olsen, Daniel Brault, Robert P. Erickson, Michael Bernas, Stephanie J. Munger, Alexander M. Simon, Seán Dineen and Christine Vever‐Bizet and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Genes & Development.

In The Last Decade

Michael T. Dellinger

53 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael T. Dellinger United States 26 1.1k 882 427 388 233 54 2.4k
Han W. Tun United States 25 1.1k 1.0× 518 0.6× 216 0.5× 414 1.1× 217 0.9× 144 2.7k
Giovanni Ligresti United States 31 1.2k 1.1× 411 0.5× 246 0.6× 639 1.6× 146 0.6× 59 2.4k
David J. Shields United States 23 1.7k 1.6× 648 0.7× 219 0.5× 357 0.9× 345 1.5× 44 3.2k
John E. Park Germany 13 1.7k 1.6× 1.0k 1.1× 299 0.7× 374 1.0× 130 0.6× 16 4.6k
Ananth Kadambi United States 10 1.0k 1.0× 749 0.8× 335 0.8× 315 0.8× 360 1.5× 25 2.1k
Eric J. Kort United States 26 1.3k 1.2× 606 0.7× 331 0.8× 583 1.5× 94 0.4× 55 2.4k
Hiroyuki Yanai Japan 25 624 0.6× 490 0.6× 386 0.9× 563 1.5× 100 0.4× 148 2.0k
Hao‐Wei Wang United States 25 703 0.7× 979 1.1× 184 0.4× 175 0.5× 215 0.9× 87 2.4k
Marian T. Nakada United States 32 1.4k 1.4× 825 0.9× 465 1.1× 305 0.8× 139 0.6× 57 3.5k
Bernhard Hemmerlein Germany 29 1.7k 1.6× 629 0.7× 352 0.8× 515 1.3× 110 0.5× 90 3.1k

Countries citing papers authored by Michael T. Dellinger

Since Specialization
Citations

This map shows the geographic impact of Michael T. Dellinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael T. Dellinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael T. Dellinger more than expected).

Fields of papers citing papers by Michael T. Dellinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael T. Dellinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael T. Dellinger. The network helps show where Michael T. Dellinger may publish in the future.

Co-authorship network of co-authors of Michael T. Dellinger

This figure shows the co-authorship network connecting the top 25 collaborators of Michael T. Dellinger. A scholar is included among the top collaborators of Michael T. Dellinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael T. Dellinger. Michael T. Dellinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dellinger, Michael T., et al.. (2023). Trametinib Inhibits Lymphatic Vessel Invasion of Bone in a Mouse Model of Gorham-Stout Disease. SHILAP Revista de lepidopterología. 4(4). e070–e070. 1 indexed citations
2.
Zhang, Jing, et al.. (2023). Hyperactive KRAS/MAPK signaling disrupts normal lymphatic vessel architecture and function. Frontiers in Cell and Developmental Biology. 11. 1276333–1276333. 9 indexed citations
3.
Helaers, Raphaël, Christine Galant, Laurence M. Boon, et al.. (2021). KRAS-driven model of Gorham-Stout disease effectively treated with trametinib. JCI Insight. 6(15). 53 indexed citations
4.
Khalid, Aysha B., et al.. (2020). Bone development and fracture healing is normal in mice that have a defect in the development of the lymphatic system. Europe PMC (PubMed Central). 2 indexed citations
5.
Zuurbier, Kielen R., et al.. (2019). Impaired meningeal lymphatic vessel development worsens stroke outcome. Journal of Cerebral Blood Flow & Metabolism. 40(2). 263–275. 91 indexed citations
6.
Kirane, Amanda, Huocong Huang, Noah Sorrelle, et al.. (2018). Cyclooxygenase-2 Inhibition Potentiates the Efficacy of Vascular Endothelial Growth Factor Blockade and Promotes an Immune Stimulatory Microenvironment in Preclinical Models of Pancreatic Cancer. Molecular Cancer Research. 17(2). 348–355. 15 indexed citations
7.
Kirane, Amanda, Kathleen Ludwig, Noah Sorrelle, et al.. (2015). Warfarin Blocks Gas6-Mediated Axl Activation Required for Pancreatic Cancer Epithelial Plasticity and Metastasis. Cancer Research. 75(18). 3699–3705. 108 indexed citations
8.
Konstantinidou, Georgia, Giorgio Ramadori, Francesca Torti, et al.. (2013). RHOA-FAK Is a Required Signaling Axis for the Maintenance of KRAS-Driven Lung Adenocarcinomas. Cancer Discovery. 3(4). 444–457. 91 indexed citations
9.
Aguilera, Kristina Y., Lee B. Rivera, Hoon Hur, et al.. (2013). Collagen Signaling Enhances Tumor Progression after Anti-VEGF Therapy in a Murine Model of Pancreatic Ductal Adenocarcinoma. Cancer Research. 74(4). 1032–1044. 76 indexed citations
10.
Wang, Lei, Jianjun Chang, Michael T. Dellinger, et al.. (2013). A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth. Nature Communications. 4(1). 2035–2035. 234 indexed citations
11.
Gerber, David E., Puja Gupta, Michael T. Dellinger, et al.. (2012). Stromal Platelet-Derived Growth Factor Receptor α (PDGFRα) Provides a Therapeutic Target Independent of Tumor Cell PDGFRα Expression in Lung Cancer Xenografts. Molecular Cancer Therapeutics. 11(11). 2473–2482. 35 indexed citations
12.
Dellinger, Michael T., et al.. (2011). Connexin37 and Connexin43 deficiencies in mice disrupt lymphatic valve development and result in lymphatic disorders including lymphedema and chylothorax. Developmental Biology. 354(2). 253–266. 143 indexed citations
13.
Zhu, Jianhua, Byeong‐ha Lee, Michael T. Dellinger, et al.. (2010). A cellulose synthase-like protein is required for osmotic stress tolerance in Arabidopsis. The Plant Journal. 63(1). no–no. 126 indexed citations
14.
Dellinger, Michael T., Robert Hunter, Michael Bernas, et al.. (2008). Defective remodeling and maturation of the lymphatic vasculature in Angiopoietin-2 deficient mice. Developmental Biology. 319(2). 309–320. 142 indexed citations
15.
Dellinger, Michael T., Robert J. Hunter, Michael Bernas, Marlys H. Witte, & Robert P. Erickson. (2007). Chy‐3 mice are Vegfc haploinsufficient and exhibit defective dermal superficial to deep lymphatic transition and dermal lymphatic hypoplasia. Developmental Dynamics. 236(8). 2346–2355. 36 indexed citations
16.
Dellinger, Michael T. & Marc Gèze. (2001). Detection of mitochondrial DNA in living animal cells with fluorescence microscopy. Journal of Microscopy. 204(3). 196–202. 21 indexed citations
17.
Dellinger, Michael T., et al.. (1992). Cytotoxic and Photodynamic Effects of Photofrin® on Sensitive and Multi-drug-resistant Friend Leukaemia Cells. International Journal of Radiation Biology. 62(6). 735–741. 16 indexed citations
18.
Brault, Daniel, Patrick Bruneval, Christine Vever‐Bizet, et al.. (1991). In vitro UPTAKE OF DICARBOXYLIC PORPHYRINS BY HUMAN ATHEROMA. KINETIC and ANALYTICAL STUDIES. Photochemistry and Photobiology. 54(2). 239–246. 9 indexed citations
19.
Dellinger, Michael T., Christine Vever‐Bizet, Daniel Brault, Giuliana Moreno, & C. Salet. (1990). UPTAKE and PHOTODYNAMIC EFFICIENCY OF HEM ATOPORPH YRIN, HYDROXYETHYLVINYLDEUTEROPORPHYRIN and HEMATOPORPHYRIN DERIVATIVE (PHOTOFRIN II®): A STUDY WITH ISOLATED MITOCHONDRIA. Photochemistry and Photobiology. 51(2). 185–189. 14 indexed citations
20.
Dellinger, Michael T. & Daniel Brault. (1987). Normal-phase high-performance liquid chromatography of free acid dicarboxylic porphyrins and hematoporphyrin derivative on silica. Journal of Chromatography B Biomedical Sciences and Applications. 422. 73–84. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Han W. Tun Breakdown of academic impact, for papers by Giovanni Ligresti Breakdown of academic impact, for papers by David J. Shields Breakdown of academic impact, for papers by John E. Park Breakdown of academic impact, for papers by Ananth Kadambi Breakdown of academic impact, for papers by Eric J. Kort Breakdown of academic impact, for papers by Hiroyuki Yanai Breakdown of academic impact, for papers by Hao‐Wei Wang Breakdown of academic impact, for papers by Marian T. Nakada Breakdown of academic impact, for papers by Bernhard Hemmerlein
Rankless by CCL
2026